Prescriptions Blog: Amgen Agreement on Anemia Drug

Friday, November 18, 2011 - 11:10 in Mathematics & Economics

Moving to protect a lucrative monopoly against impending competition, Amgen has reached an agreement that will preserve its status as the main supplier of anemia drugs to one of the nation's two large kidney dialysis chains.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net